Neural Regeneration Research ›› 2016, Vol. 11 ›› Issue (12): 1910-1911.doi: 10.4103/1673-5374.195272

Previous Articles     Next Articles

TDP-43 overexpression impairs presynaptic integrity

Lanier Heyburn, Charbel E-H. Moussa*   

  1. Department of Neurology, Laboratory for Dementia and Parkinsonism, Translational Neurotherapeutics Program, Georgetown University Medical Center, Washington D.C., USA
  • Received:2016-11-12 Online:2016-12-31 Published:2016-12-31
  • Contact: Charbel E-H. Moussa, M.D., Ph.D., cem46@georgetown.edu.
  • Supported by:
    These studies were supported by Georgetown University funding to Moussa CE. Moussa CE, M.D., Ph.D., is listed as an inventor on a pending U.S. patent application to use tyrosine kinase inhibitors as a treatment for neurodegenerative diseases.

PDF

734